Welcome to Molecular Psychiatry
Molecular Psychiatry publishes definitive, high-impact work that elucidates key issues in psychiatry and related fields. The emphasis is on bringing together in one journal the best pre-clinical and clinical research, including research at the cellular, molecular, integrative, epidemiological, translational, clinical, imaging, psychopharmacology, and treatment outcome levels. Cutting-edge articles are highly cited in the fields of psychiatry, psychology, neuroscience, biochemistry & molecular biology.
About the cover
Free online issue
Volume 14, No 1
January 2009
ISSN: 1359-4184
EISSN: 1476-5578
Impact Factor 10.900*
2/94 Psychiatry
7/211 Neuroscience
13/263 Biochemistry & Molecular Biology
Editor:
Julio Licinio, MD
*2007 Journal Citation Report (Thomson Reuters, 2008)
FEATURED ARTICLES
GUEST EDITORIAL
Chromaffin progenitors in neurodegenerative diseases FREEORIGINAL ARTICLE
Continuous CRF synthesis in CeA simulates chronic stress FREEORIGINAL ARTICLE
Mood stabilizers activate BDNF promoter IV FREEORIGINAL ARTICLE
Wolframine in PTSD FREENEWS
There are, to date, no objective clinical laboratory blood tests for mood disorders. Current reliance on patients self-reporting symptom severity, and on the impressions of clinicians, is a rate limiting step in effective treatment and new drug development. These studies suggest blood biomarkers may offer an unexpectedly informative window into brain functioning and disease state.
One in eight US adults smoke a pack of cigarettes a day and most of the risk of habitual heavy smoking (nicotine addiction) is genetic. This paper studied DNA samples from 14,000 people and showed the most important genetic predictors of nicotine addiction are variants in genes that produce the brain proteins to which nicotine binds.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
